Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 4941-4947

  Kent, Stephen J ^a,c   Hu, Shiu Lok ^b   Corey, Lawrence ^a   Morton, William R ^a   Greenberg, Philip D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^c MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; HOST RESISTANCE; INFECTION PREVENTION; LYMPHOCYTE SUBPOPULATION; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VACCINATION;

EID: 0029900651     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.4941-4947.1996     Document Type: Article

References (41)

1. Biswas, P., G. Poli, J. M. Orenstein, and A. S. Fauci. 1994. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? J. Virol. 68:2598-2604.
2. Bollinger, R. C., T. C. Quinn, A. Y. Liu, P. E. Stanhope, S. A. Hammond, R. Viveen, M. L. Clements, and R. F. Siliciano. 1993. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication. AIDS Res. Hum. Retroviruses 9:1067-1077.
3. Brochier, B., M. P. Kieny, F. Costy, P. Coppens, B. Bauduin, J. P. Lecocq, B. Languet, G. Chappuis, P. Desmettre, K. Afiademanyo, et al. 1991. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature (London) 354:520-522.
4. Cheynier, R., P. Langlade-Demoyen, M. R. Marescot, S. Blanche, G. Blondin, S. Wain-Hobson, C. Griscelli, E. Vilmer, and F. Plata. 1992. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur. J. Immunol. 22: 2211-2217.
5. Cooney, E. L., M. J. McElrath, L. Corey, S. L. Hu, A. C. Collier, D. Arditti, M. Hoffman, R. W. Coombs, G. E. Smith, and P. D. Greenberg. 1993. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc. Natl. Acad. Sci. USA 90:1882-1886.
6. Daar, E. S., T. Moudgil, R. D. Meyer, and D. D. Ho. 1991. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Engl. J. Med. 324:961-964.
7. Demkowicz, W. E., R. A. Littaua, J. Wang, and F. A. Ennis. 1996. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol. 70:2627-2631.
8. Edmonson, M. B., D. G. Addiss, J. T. McPherson, J. L. Berg, S. R. Circo, and J. P. Davis. 1990. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 263:2467-2471.
9. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011-1018.
10. Gray, D., and P. Matzinger. 1991. T cell memory is short-lived in the absence of antigen. J. Exp. Med. 174:969-974.
11. Heeney, J. L., C. van-Els, P. de-Vries, P. ten-Haaft, N. Otting, W. Koornstra, J. Boes, R. Dubbes, H. Niphuis, M. Dings, et al. 1994. Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J. Exp. Med. 180:769-774.
12. Hou, S., L. Hyland, K. W. Ryan, A. Portner, and P. C. Doherty. 1994. Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature (London) 369:652-654.
13. Hu, S.-L. Unpublished data.
14. Hu, S. L., K. Abrams, G. N. Barber, P. Moran, J. M. Zarling, A. J. Langlois, L. Kuller, W. R. Morton, and R. E. Benveniste. 1992. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255:456-459.
15. Hu, S. L., K. Abrams, L. Misher, V. Stallard, P. Moran, J. M. Zarling, A. J. Langlois, L. Kuller, W. R. Morton, and R. E. Benveniste. 1992. Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques. J. Med. Primatol. 21:119-125.
16. Hu, S.-L., P. Polacino, V. Stallard, J. Klaniecki, S. Pennathur, B. M. Travis, L. Misher, H. Kornas, W. M. Morton, A. J. Langlois, and R. E. Benveniste. 1995. Transmembrane protein and core antigens in protection against SIV infection, p. 167-173. In R. Chanock, R. Lerner, F. Brown, and H. Ginsberg (ed.), Vaccines 95. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
17. Hu, S. L., V. Stallard, K. Abrams, G. N. Barber, L. Kuller, A. J. Langlois, W. R. Morton, and R. E. Benveniste. 1993. Protection of vaccinia-primed macaques against SIVmne infection by combination immunization with recombinant vaccinia virus and SIVmne gp160. J. Med. Primatol. 22:92-99.
18. Hu, S. L., B. M. Travis, V. Stallard, K. Abrams, L. Misher, P. Moran, J. M. Zarling, A. J. Langlois, L. Kuller, W. R. Morton, et al. 1992. Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection. AIDS Res. Hum. Retroviruses 8:1489-1494.
19. Johnson, C., L. P. Rome, T. Stancin, and M. L. Kumar. 1989. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics 84:418-421.
20. Kent, S. J. Unpublished data.
21. Kent, S. J., L. Corey, M. B. Agy, W. R. Morton, M. J. McElrath, and P. D. Greenberg. 1995. Cytotoxic and proliferative T cell responses in HIV-1 infected M. nemestrina. J. Clin. Invest. 95:248-256.
22. Kent, S. J., V. Stallard, L. Corey, S.-L. Hu, W. R. Morton, L. Gritz, D. L. Panicali, and P. D. Greenberg. 1994. Analysis of CTL responses to SIV proteins in SIV infected macaques using antigen specific stimulation with recombinant vaccinia and fowlpox viruses. AIDS Res. Hum. Retroviruses 10:551-560.
23. Kuller, L., W. R. Morton, R. E. Benveniste, C. C. Tsai, E. A. Clark, M, J. Gale, S. L. Hu, M. E. Thouless, and M. G. Katze. 1990. Inoculation of Macaca fascicularis with simian immunodeficiency virus, SIVmne immunologic, serologic, and pathologic changes. J. Med. Primatol. 19:367-380.
24. Langlade-Demoyen, P., N. Ngo-Giang-Huong, F. Ferchal, and E. Oksenhendler. 1994. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J. Clin. Invest. 93:1293-1297.
25. Lau, L. L., B. D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature (London) 369:648-652.
26. Letvin, N. L. 1993. Vaccines against human immunodeficiency virus-progress and prospects. N. Engl. J. Med. 329:1400-1405.
27. Montefiori, D. C., K. A. Reimann, N. L. Letvin, J. Zhou, and S.-L. Hu. 1995. Studies of complement-activating antibodies in the SIV/macaque model of acute primary infection and vaccine protection. AIDS Res. Hum. Retroviruses 11:963-970.
28. Mullbacher, A. 1994. The long-term maintenance of eytotoxic T cell memory does not require persistence of antigen. J. Exp. Med. 179:317-321.
29. Nuchtern, J. G., J. S. Bonifacino, W. E. Biddison, and R, D. Klausner. 1989. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature (London) 339:223-226.
30. Oehen, S., H. Waldner, T. M. Kundig, H. Hengartner, and R. M. Zinkernagel. 1992. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J. Exp. Med. 176: 1273-1281.
31. Piatak, M., Jr., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
32. Poovorawan, Y., S. Sanpavat, W. Pongpunlert, S. Chumdermpadetsuk, P. Sentrakul, and A. Safary. 1989. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 261:3278-3281.
33. Renegar, K. B., and P. A. Small, Jr. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1972-1978.
34. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
35. Rowland-Jones, S. L., D. F. Nixon, M. C. Aldhous, F. Gotch, K, Ariyoshi, N. Hallam, J. S. Kroll, K. Froebel, and A. McMichael. 1993. HIV-specific cytotoxic T-cell activity in an HIV-exposcd but uninfected infant. Lancet 341:860-861.
36. Sabin, A. B. 1992. Improbability of effective vaccination against human immunodeficiency virus because of its intracellular transmission and rectal portal of entry. Proc. Natl. Acad. Sci. USA 89:8852-8855.
37. Salk, J., P. A. Bretscher, P. L. Salk, M. Clerici, and G. M. Shearer. 1993. A strategy for prophylactic vaccination against HIV. Science 260:1270-1272.
38. Schultz, A. M., and S. L. Hu. 1993. Primate models for HIV vaccines. AIDS 1:S161-S170.
39. Stallard, G., K. Kornas, J. Thompson, R. Nolte, J. Klaniecki, C. Bartz, W. Morton, A. Langlois, R. Benveniste, and S.-L. Hu. 1994. Limits of protective immunity generated by SIVmne gp160 vaccines against cell-free homologous virus challenge. AIDS Res. Hum. Retroviruses 10:S137.
40. Taswell, C. 1981. Limiting dilution assays for the determination of immuno-competent cell frequencies. I. Data analysis. J. Immunol. 126:1614-1619.
41. Yewdell, J. W., and J. R. Bennink. 1989. Brefeldin A specifically inhibits presentation of protein antigens to eytotoxic T lymphocytes. Science 244: 1072-1075.